Listed companies focus on hard technology integration, driving value reconstruction
Researchers at Harbin Medical University have developed a new blood analysis platform that integrates AI with surface-enhanced Raman spectroscopy. This innovative approach allows for the detection of metabolic molecules in blood, offering a less invasive method for screening Alzheimer's disease. The findings, published in the Journal of Analytical Chemistry, represent a significant advancement in diagnostic technology. AI
IMPACT This AI-enhanced diagnostic tool could lead to earlier and less invasive detection of Alzheimer's disease.